ACAPELLA is the European multicenter clinical trial evaluating Alpha DaRT alpha-emitter radiotherapeutics combined with capecitabine for ...
A new index maps 'brainrot' levels across US states, revealing which states have the most digital overstimulation. Where does ...
Alkane Resources looks undervalued vs. NPV, with Boda-Kaiser upside and June 2026 catalyst. Read here for a detailed ...
TeamHive ( the evidence-based team effectiveness platform, today announced the public launch of its Free Team Effectiveness Indicator -- a diagnostic tool that enables any leader, team member, or team ...
At this time, I would like to welcome everyone to the Nauticus Robotics Inc. 2025 Fourth Quarter Earnings Call. [Operator Instructions] It is now my pleasure to turn today's call over to Kristin ...
AstraZeneca’s SAPHNELO ® (anifrolumab-fnia) has been approved in the US for self-administration as a once-weekly autoinjector ...
AstraZeneca's Saphnelo (anifrolumab) has been approved in the US for self-administration as a once-weekly autoinjector, the Saphnelo Pen, for the ...
Looking at the best games for building lunar settlements, and how they compare to NASA's real-life plans for Artemis Base ...
Lindenwood hosted its first-ever combined Showcase yesterday, April 23, 2026, bringing together the previous Student Academic ...
Letrozole monotherapy failed to show noninferiority compared to standard chemotherapy followed by letrozole as a first-line ...
In this episode, Ray Cochrane unpacks Anthropic's Mythos model and the Treasury's emergency meetings with Wall Street, then ...
IDE supplement expands trial to the other primary standard-of-care chemotherapy for pancreatic cancer patients, alongside mFOLFIRINOX -- IDE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results